What is myasthenia gravis, the rare disease tennis great Monica Seles lives with?
Former tennis star Monica Seles recently revealed she is living with the rare disease myasthenia gravis, which affects 12 in 100,000 people globally.
Nov 10, 2025
0
0
Former tennis star Monica Seles recently revealed she is living with the rare disease myasthenia gravis, which affects 12 in 100,000 people globally.
Nov 10, 2025
0
0
Our immune system has a dark side: It's supposed to fight off invaders to keep us healthy. But sometimes it turns traitor and attacks our own cells and tissues.
Nov 6, 2025
0
0
UNC School of Medicine researchers have led an international clinical trial of patients with generalized myasthenia gravis, finding the therapy is safe and effective across all subtypes.
Nov 6, 2025
0
0
Autoimmune neuromuscular diseases may sound complex, but understanding them is the first step to getting the right care and support. Conditions such as Lambert-Eaton myasthenic syndrome (LEMS), myasthenia gravis (MG), and ...
Oct 23, 2025
0
0
Former tennis star Monica Seles has revealed she has been diagnosed with myasthenia gravis, a rare autoimmune condition that affects how the muscles work. The multiple Grand Slam champion says she was actually diagnosed three ...
Aug 28, 2025
0
0
An AI-powered tool from Carnegie Mellon University and collaborators is helping uncover genetic clues to rare diseases, potentially accelerating diagnoses and treatments for conditions that affect only a fraction of the population.
Aug 5, 2025
0
0
A team of physicians from Bochum are the first to successfully use CAR T-cell therapy to treat two patients with a rare autoimmune disease of the peripheral nervous system. This treatment modifies endogenous immune cells ...
Jun 18, 2025
0
216
Your bile duct network is a true tree of life. A floppy, pink tree of life.
May 15, 2025
0
0
Myasthenia gravis (MG) is a rare, chronic autoimmune disorder that disrupts the communication between nerves and muscles. It typically leads to symptoms such as muscle weakness, drooping eyelids, difficulty swallowing, fatigue, ...
May 13, 2025
0
7
The U.S. Food and Drug Administration has approved a self-injection version of Vyvgart Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) for the treatment of adult patients with generalized myasthenia gravis (gMG) who are ...
Apr 16, 2025
0
0
Myasthenia gravis (from Greek μύς "muscle", ἀσθένεια "weakness", and Latin: gravis "serious"; abbreviated MG) is an autoimmune neuromuscular disease leading to fluctuating muscle weakness and fatiguability. It is an autoimmune disorder, in which weakness is caused by circulating antibodies that block acetylcholine receptors at the postsynaptic neuromuscular junction, inhibiting the excitatory effects of the neurotransmitter acetylcholine on nicotinic receptors throughout neuromuscular junctions. Myasthenia is treated medically with cholinesterase inhibitors or immunosuppressants, and, in selected cases, thymectomy. The disease incidence is 3–30 cases per million per year and rising as a result of increased awareness. MG must be distinguished from congenital myasthenic syndromes that can present similar symptoms but offer no response to immunosuppressive treatments.
This text uses material from Wikipedia licensed under CC BY-SA